LABCORP HOLDINGS INC. (LH) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 900.00K USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 5.86B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 18.53B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $900.00K | $5.86B | (m) | (m) | $18.53B | (m) |
| 2026-03-31 | (m) | (m) | $500.40M | $5.83B | (m) | (m) | $19.09B | (m) |
| 2025-12-31 | (m) | (m) | $500.10M | $5.08B | (m) | (m) | $18.39B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $5.08B | (m) | (m) | $18.26B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $5.08B | (m) | (m) | $18.06B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $5.57B | (m) | (m) | $17.60B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $5.33B | (m) | (m) | $18.38B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $5.35B | (m) | (m) | $18.61B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $3.05B | (m) | (m) | $16.71B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $3.05B | (m) | (m) | $16.53B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $4.05B | (m) | (m) | $16.73B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $4.43B | (m) | (m) | $16.89B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $5.04B | (m) | (m) | $17.72B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $5.05B | (m) | (m) | $20.20B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $5.04B | (m) | (m) | $20.16B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $5.33B | (m) | (m) | $19.83B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $5.36B | (m) | (m) | $20.40B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $5.38B | (m) | (m) | $20.73B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $5.42B | (m) | (m) | $20.39B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $5.42B | (m) | (m) | $20.87B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $5.42B | (m) | (m) | $20.42B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $4.92B | (m) | (m) | $20.42B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $5.42B | (m) | (m) | $20.07B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $5.42B | (m) | (m) | $18.74B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $5.42B | (m) | (m) | $17.85B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $5.79B | (m) | (m) | $17.30B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $5.79B | (m) | (m) | $18.05B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $6.10B | (m) | (m) | $17.85B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $6.13B | (m) | (m) | $17.74B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $5.50B | (m) | (m) | $16.97B | (m) |
| 2018-12-31 | (m) | (m) | $10.00M | $6.04B | (m) | (m) | $16.19B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $6.04B | (m) | (m) | $16.66B | (m) |
| 2018-06-30 | (m) | (m) | (m) | $6.04B | (m) | (m) | $16.50B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $6.36B | (m) | (m) | $16.83B | (m) |
| 2017-12-31 | (m) | (m) | $409.20M | $6.34B | (m) | (m) | $16.57B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $7.20B | (m) | (m) | $16.69B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $5.61B | (m) | (m) | $14.90B | (m) |
| 2017-03-31 | (m) | (m) | (m) | $5.40B | (m) | (m) | $14.43B | (m) |
| 2016-12-31 | (m) | (m) | $541.10M | $5.30B | (m) | (m) | $14.25B | (m) |
| 2016-09-30 | (m) | (m) | (m) | $5.47B | (m) | (m) | $14.48B | (m) |
| 2016-06-30 | (m) | (m) | (m) | $5.97B | (m) | (m) | $14.20B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $5.97B | (m) | (m) | $14.41B | (m) |
| 2015-12-31 | (m) | (m) | $419.50M | $5.99B | (m) | (m) | $14.22B | (m) |
| 2015-09-30 | (m) | (m) | (m) | $6.01B | (m) | (m) | $14.42B | (m) |
| 2015-06-30 | (m) | (m) | (m) | $6.11B | (m) | (m) | $14.47B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $6.60B | (m) | (m) | $14.15B | (m) |
| 2014-12-31 | (m) | (m) | $343.90M | $2.68B | (m) | (m) | $7.30B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $2.92B | (m) | (m) | $7.23B | (m) |
| 2014-06-30 | (m) | (m) | (m) | $2.91B | (m) | (m) | $7.14B | (m) |
| 2014-03-31 | (m) | (m) | (m) | $2.90B | (m) | (m) | $6.99B | (m) |
| 2013-12-31 | (m) | (m) | $110.80M | $2.89B | (m) | (m) | $6.97B | (m) |
| 2013-09-30 | (m) | (m) | (m) | $2.55B | (m) | (m) | $6.69B | (m) |
| 2013-06-30 | (m) | (m) | (m) | $2.39B | (m) | (m) | $6.59B | (m) |
| 2013-03-31 | (m) | (m) | (m) | $2.17B | (m) | (m) | $6.57B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $2.17B | (m) | (m) | $6.79B | (m) |
| 2012-09-30 | (m) | (m) | (m) | $2.17B | (m) | (m) | $6.81B | (m) |
| 2012-06-30 | (m) | (m) | (m) | $1.98B | (m) | (m) | $6.10B | (m) |
| 2012-03-31 | (m) | (m) | (m) | $1.99B | (m) | (m) | $6.13B | (m) |
| 2011-12-31 | (m) | (m) | (m) | $2.09B | (m) | (m) | $6.14B | (m) |
| 2011-09-30 | (m) | (m) | (m) | $1.77B | (m) | (m) | $6.05B | (m) |
| 2011-06-30 | (m) | (m) | (m) | $1.79B | (m) | (m) | $6.17B | (m) |
| 2011-03-31 | (m) | (m) | (m) | $1.81B | (m) | (m) | $6.20B | (m) |
| 2010-12-31 | (m) | (m) | (m) | $1.83B | (m) | (m) | $6.19B | (m) |
| 2010-09-30 | (m) | (m) | (m) | $920.60M | (m) | (m) | $5.05B | (m) |
| 2010-06-30 | (m) | (m) | (m) | $939.40M | (m) | (m) | $4.96B | (m) |
| 2010-03-31 | (m) | (m) | (m) | $958.30M | (m) | (m) | $4.93B | (m) |
| 2009-12-31 | (m) | (m) | (m) | $977.20M | (m) | (m) | $4.84B | (m) |
| 2009-09-30 | (m) | (m) | (m) | $1.28B | (m) | (m) | $4.83B | (m) |
| 2009-06-30 | (m) | (m) | (m) | $1.29B | (m) | (m) | $4.71B | (m) |
| 2008-12-31 | (m) | (m) | (m) | $1.60B | (m) | (m) | $4.67B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |